{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:09:57Z","timestamp":1767182997396},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12348-016-0107-y","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T08:39:53Z","timestamp":1476261593000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Refractory necrotizing scleritis successfully treated with adalimumab"],"prefix":"10.1186","volume":"6","author":[{"given":"Lola E.","family":"Lawuyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avinash","family":"Gurbaxani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,12]]},"reference":[{"key":"107_CR1","volume-title":"Uveitis: fundamentals and clinical practice","author":"RB Nussenbalt","year":"2010","unstructured":"Nussenbalt RB, Whitcup SM (2010) Uveitis: fundamentals and clinical practice, 4th edn. Elsevier, Philadelphia","edition":"4"},{"key":"107_CR2","unstructured":"Garg SJ. Wills Eye Institute- Uveitis (Colour Atlas and Synopsis of Clinical Ophthalmology). Lippincott Williams & Wilkins; 2012"},{"issue":"6","key":"107_CR3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jlb.61.6.667","volume":"61","author":"N Girolamo Di","year":"1997","unstructured":"Di Girolamo N, Visvanathan K, Lloyd A, Wakefield D (1997) Expression of TNF-alpha by human plasma cells in chronic inflammation. J Leukoc Biol 61(6):667\u2013678","journal-title":"J Leukoc Biol"},{"issue":"2","key":"107_CR4","first-page":"653","volume":"150","author":"N Girolamo Di","year":"1997","unstructured":"Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D (1997) Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol 150(2):653\u2013666","journal-title":"Am J Pathol"},{"issue":"1","key":"107_CR5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/03009740802366076","volume":"38","author":"R Lopez Gonzalez","year":"2009","unstructured":"Lopez Gonzalez R, Loza E, Jover JA et al (2009) Treatment for refractory posterior uveitis with infliximab: a 7-year follow-up study. Scand J Rheumatol 38(1):58\u201362","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"107_CR6","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3129\/i09-061","volume":"44","author":"HN Sen","year":"2009","unstructured":"Sen HN, Sangave A, Hammel K et al (2009) Infliximab for the treatment of active scleritis. Can J Ophthalmol 44(3):e9\u2013e12","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"107_CR7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/09273948.2013.863944","volume":"22","author":"A Ragum","year":"2014","unstructured":"Ragum A, Kolomeyer AM, Fang C, Xu Y, Chu DS (2014) Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors. Ocul Immunol Inflamm 22(6):469\u2013477","journal-title":"Ocul Immunol Inflamm."},{"issue":"3","key":"107_CR8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0974-620X.91271","volume":"4","author":"AM Bawazeer","year":"2011","unstructured":"Bawazeer AM, Raffa LH (2011) Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis. Oman J Ophthalmol 4(3):139\u2013141","journal-title":"Oman J Ophthalmol"},{"issue":"5","key":"107_CR9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10067-009-1368-8","volume":"29","author":"JP Restrepo","year":"2010","unstructured":"Restrepo JP, Molina MP (2010) Successful treatment of severe nodular scleritis with adalimumab. Clin Rheumatol 29(5):559\u2013561","journal-title":"Clin Rheumatol"},{"key":"107_CR10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000342842","volume":"3","author":"J Morarji","year":"2012","unstructured":"Morarji J, Joshi L, Tomkins-Netzer O, Lightman S, Taylor SRJ (2012) Combined infliximab and rituximab in necrotising scleritis. Case Rep Ophthalmol 3:286\u2013290","journal-title":"Case Rep Ophthalmol"},{"key":"107_CR11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaut.2007.02.001","volume":"28","author":"M Blank","year":"2007","unstructured":"Blank M, Shoenfeld Y (2007) B cell targeted therapy in autoimmunity. J Autoimmun 28:62\u201368","journal-title":"J Autoimmun"},{"issue":"Suppl 6","key":"107_CR12","doi-asserted-by":"crossref","first-page":"vi37","DOI":"10.1093\/rheumatology\/kes283","volume":"51","author":"EM Ruderman","year":"2012","unstructured":"Ruderman EM (2012) Overview of safety of non-biologic and biologic DMARDs. Rheumatology 51(Suppl 6):vi37\u2013vi43","journal-title":"Rheumatology"},{"issue":"15","key":"107_CR13","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345(15):1098\u20131104","journal-title":"N Engl J Med"},{"issue":"12","key":"107_CR14","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1177\/1352458511412996","volume":"17","author":"AJ Solomon","year":"2011","unstructured":"Solomon AJ, Spain RI, Kruer MC et al (2011) Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Mult Scler 17(12):1472\u20131487","journal-title":"Mult Scler"},{"key":"107_CR15","doi-asserted-by":"crossref","unstructured":"British Society for Rheumatology (2005) Update on the British Society for Rheumatology. Rheumatology guidelines for prescribing TNF\u03b1 blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 44(2):157\u2013163, [Online] [Access 2015 November]. Available from URL http:\/\/rheumatology.oxfordjournals.org","DOI":"10.1093\/rheumatology\/keh464"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-016-0107-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12348-016-0107-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-016-0107-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T13:40:04Z","timestamp":1568468404000},"score":1,"resource":{"primary":{"URL":"http:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-016-0107-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["107"],"URL":"https:\/\/doi.org\/10.1186\/s12348-016-0107-y","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,12]]},"article-number":"37"}}